Page last updated: 2024-10-24

phospholipid transport

Definition

Target type: biologicalprocess

The directed movement of phospholipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Phospholipids are any lipids containing phosphoric acid as a mono- or diester. [GOC:ai]

Phospholipid transport is a fundamental biological process responsible for the movement of phospholipids throughout cells and between cellular compartments. Phospholipids are essential components of cell membranes, playing crucial roles in membrane fluidity, permeability, and signal transduction. Their transport involves a complex network of specialized proteins and pathways.

**1. Intracellular Transport:**

* **Vesicular Transport:** Phospholipids are packaged into vesicles, small membrane-bound sacs, which bud off from the endoplasmic reticulum (ER), the primary site of phospholipid biosynthesis. These vesicles then transport phospholipids to other organelles, such as the Golgi apparatus, plasma membrane, and lysosomes.

* **Non-vesicular Transport:** Some phospholipids move directly between membranes through specific protein channels. These channels, often called scramblases or flippases, facilitate the movement of phospholipids across the membrane bilayer.

**2. Intercellular Transport:**

* **Lipoprotein Transport:** Phospholipids are transported between cells through lipoprotein particles. These particles consist of a core of triglycerides and cholesterol esters surrounded by a phospholipid monolayer. Lipoproteins play a vital role in delivering lipids to different tissues.

* **Exocytosis and Endocytosis:** Phospholipids are also transported between cells through exocytosis (release from the cell) and endocytosis (uptake by the cell). These processes involve the formation and fusion of vesicles with the plasma membrane.

**3. Regulation of Phospholipid Transport:**

* **Phospholipid Translocases:** These enzymes, including flippases, floppases, and scramblases, regulate the movement of phospholipids between the two leaflets of the membrane bilayer.

* **Lipid Binding Proteins:** Proteins that specifically bind to phospholipids play a role in transporting them to their destinations.

* **Signal Transduction Pathways:** Phospholipid transport can be regulated by various signaling pathways, including those involving hormones and growth factors.

**4. Importance of Phospholipid Transport:**

* **Membrane Biogenesis:** Phospholipid transport is crucial for maintaining the integrity and function of cellular membranes.

* **Signal Transduction:** Phospholipids act as signaling molecules and are involved in a variety of cellular processes.

* **Cellular Growth and Differentiation:** Phospholipid transport is essential for cell growth, division, and differentiation.

* **Disease Pathogenesis:** Disruptions in phospholipid transport can contribute to various diseases, including cardiovascular disease, neurodegenerative disorders, and cancer.'
"

Proteins (4)

ProteinDefinitionTaxonomy
Scavenger receptor class B member 1A scavenger receptor class B member 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8WTV0]Homo sapiens (human)
Microsomal triglyceride transfer protein large subunitA microsomal triglyceride transfer protein large subunit that is encoded in the genome of human. [PRO:HJD, UniProtKB:P55157]Homo sapiens (human)
Cholesteryl ester transfer proteinA cholesteryl ester transfer protein that is encoded in the genome of human. [PRO:DNx, UniProtKB:P11597]Homo sapiens (human)
Low-density lipoprotein receptorA low-density lipoprotein receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:P01130]Homo sapiens (human)

Compounds (25)

CompoundDefinitionClassesRoles
niacinNiacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.

nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.

vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
pyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3
antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
nevirapinenevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
cyclopropanes;
dipyridodiazepine
antiviral drug;
HIV-1 reverse transcriptase inhibitor
rimcazolerimcazole: RN given refers to (cis)-isomer; structure given in first sourcecarbazoles
efavirenzefavirenz : 1,4-Dihydro-2H-3,1-benzoxazin-2-one substituted at the 4 position by cyclopropylethynyl and trifluoromethyl groups (S configuration) and at the 6 position by chlorine. A non-nucleoside reverse transcriptase inhibitor with activity against HIV, it is used with other antiretrovirals for combination therapy of HIV infection.

efavirenz: HIV-1 reverse transcriptase inhibitor
acetylenic compound;
benzoxazine;
cyclopropanes;
organochlorine compound;
organofluorine compound
antiviral drug;
HIV-1 reverse transcriptase inhibitor
ursolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
geroprotector;
plant metabolite
torcetrapib(trifluoromethyl)benzenes;
carbamate ester;
quinolines
anticholesteremic drug;
CETP inhibitor
sb 203580imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
delta-8-tetrahydrocannabinol1-benzopyran
s 1033(trifluoromethyl)benzenes;
imidazoles;
pyridines;
pyrimidines;
secondary amino compound;
secondary carboxamide
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: structure in first source

alvespimycin : A 19-membered macrocyle that is geldanamycin in which the methoxy group attached to the benzoquinone moiety has been replaced by a 2-(N,N-dimethylamino)ethylamino group.
1,4-benzoquinones;
ansamycin;
carbamate ester;
secondary amino compound;
tertiary amino compound
Hsp90 inhibitor
tanespimycinCP 127374: analog of herbimycin A1,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
dalcetrapibdalcetrapib: inhibits cholesteryl ester transfer protein (CETP)anilide
am-411
sc 795
3-((3-(4-chloro-3-ethylphenoxy)phenyl)(3-(1,1,2,2-tetrafluoroethoxy)benzyl)amino)-1,1,1-trifluoropropan-2-ol3-((3-(4-chloro-3-ethylphenoxy)phenyl)(3-(1,1,2,2-tetrafluoroethoxy)benzyl)amino)-1,1,1-trifluoropropan-2-ol: inhibits cholesteryl ester transfer protein; structure in first source
bms201038BMS201038: an anticholesteremic agent and microsomal triglycide transfer protein inhibitor

lomitapide : A member of the class of benzamides obtained by formal condensation of the carboxy group of 4'-(trifluoromethyl)biphenyl-2-carboxylic acid with the primary amino group of 9-[4-(4-aminopiperidin-1-yl)butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide. Used (as its mesylate salt) as a complement to a low-fat diet and other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia.
(trifluoromethyl)benzenes;
benzamides;
fluorenes;
piperidines
anticholesteremic drug;
MTP inhibitor
dirlotapidedirlotapide: structure in first source
amg 3AMG 3: structure in first source
km-233KM-233: used for the treatment of high-grade glioma; structure in first source
mk 0354
anacetrapib
gdc 0941pictrelisib : A sulfonamide composed of indazole, morpholine, and methylsulfonyl-substituted piperazine rings bound to a thienopyrimidine ring.indazoles;
morpholines;
piperazines;
sulfonamide;
thienopyrimidine
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
jnj-31020028
skepinone-lskepinone-L: a dibenzosuberone-type p38 MAPK inhibitor; structure in first source
evacetrapibbenzazepine